Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,085 | Dovepress* | 3,533+ | 111 | 3,644 | |
| PubMed Central* | 552 | 111 | 663 | ||
| Totals | 4,085 | 222 | 4,307 | ||
| *Since 28 December 2022 | |||||
View citations on PubMed Central and Google Scholar